[Antineoplastic effect and chemical structure of protamines of various origin].
D000409:Alanine / Q000032:analysis; D000596:Amino Acids / Q000032:analysis*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001120:Arginine / Q000032:analysis; D001224:Aspartic Acid / Q000032:analysis; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003864:Depression, Chemical; D005399:Fishes; D005971:Glutamates / Q000032:analysis; D005998:Glycine / Q000032:analysis; D006639:Histidine / Q000032:analysis; D006863:Hydrogen-Ion Concentration; D007930:Leucine / Q000032:analysis; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008239:Lysine / Q000032:analysis; D008715:Methionine / Q000032:analysis; D051379:Mice; D011392:Proline / Q000032:analysis; D011479:Protamines / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D012511:Sarcoma 37 / Q000188:drug therapy*; D012694:Serine / Q000032:analysis; D013912:Threonine / Q000032:analysis
D000596:Amino Acids; D000970:Antineoplastic Agents; D005971:Glutamates; D011479:Protamines; D013912:Threonine; D001224:Aspartic Acid; D012694:Serine; D006639:Histidine; D001120:Arginine; D011392:Proline; D008715:Methionine; D007930:Leucine; D008239:Lysine; D000409:Alanine; D005998:Glycine
Protivoopukholevaia aktivnost' i khimicheskoe stroenie protaminov razlichnogo proiskhozhdeniia.